| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 812.97B | 737.38B | 642.81B | 631.51B | 607.66B |
| Gross Profit | 92.61B | 81.67B | 68.73B | 71.80B | 67.47B |
| EBITDA | 66.27B | 56.18B | 47.23B | 52.25B | 50.82B |
| Net Income | 23.64B | 19.25B | 14.56B | 19.01B | 17.25B |
Balance Sheet | |||||
| Total Assets | 790.07B | 770.84B | 689.52B | 703.89B | 685.27B |
| Cash, Cash Equivalents and Short-Term Investments | 87.82B | 85.12B | 83.47B | 109.75B | 108.49B |
| Total Debt | 91.26B | 125.95B | 47.34B | 50.15B | 50.17B |
| Total Liabilities | 318.80B | 347.26B | 253.94B | 254.16B | 251.74B |
| Stockholders Equity | 443.61B | 397.00B | 430.38B | 444.85B | 429.89B |
Cash Flow | |||||
| Free Cash Flow | 19.12B | 14.62B | 25.04B | 14.34B | 16.14B |
| Operating Cash Flow | 56.59B | 52.75B | 48.44B | 39.27B | 45.53B |
| Investing Cash Flow | -32.98B | -69.51B | -24.51B | -29.59B | -31.79B |
| Financing Cash Flow | -17.01B | 18.59B | -49.65B | -8.17B | -7.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥19.73B | 7.14 | ― | 2.46% | 0.69% | 11.33% | |
73 Outperform | ¥393.46B | 15.45 | 5.53% | 4.35% | 10.25% | 36.09% | |
73 Outperform | ¥116.45B | 12.80 | ― | 3.57% | 3.07% | -0.96% | |
65 Neutral | ¥23.95B | 11.42 | ― | 2.82% | 2.71% | -5.60% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥252.18B | 14.37 | 4.72% | 1.66% | 5.32% | 71.96% | |
50 Neutral | ¥610.44B | -12.02 | 7.44% | 2.10% | 5.84% | -61.24% |